Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis.
Saved in:
| Title: | Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis. |
|---|---|
| Authors: | Tarkiainen, Maarit1,2,3 (AUTHOR) maarit.tarkiainen@helsinki.fi, Tynjälä, Pirjo2,3 (AUTHOR), Vähäsalo, Paula4,5 (AUTHOR), Aalto, Kristiina1,2,3 (AUTHOR), Kröger, Liisa6 (AUTHOR), Rebane, Katariina1,2,3 (AUTHOR), Lahdenne, Pekka1,2,3 (AUTHOR), Martikainen, Janne7 (AUTHOR) |
| Source: | Pediatric Rheumatology. 11/16/2022, Vol. 20 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 15460096 |
|---|---|
| DOI: | 10.1186/s12969-022-00748-w |
